Baxter Names John Rogers CFO Effective October 1, Hiring Him Away From Smith+Nephew

Baxter International named John Rogers Executive Vice President and Chief Financial Officer, effective 1 October 2026, the Deerfield, Illinois company said on 19 August 2026 in a Form 8-K and an accompanying press release. Rogers, 58, has been CFO of Smith+Nephew plc since 2024 and reports to President and CEO Andrew Hider. Baxter's offer letter sets his base salary at $925,000 and makes his first day contingent on US work authorization.

Who is John Rogers?

Rogers is a finance executive with senior roles in retail, advertising and medical technology. Baxter's 8-K lists his career, which the table below summarizes from that filing.

The 8-K says he holds a master's degree in electrical engineering from Imperial College London and an MBA from INSEAD. He also completed the Advanced Management Program at Harvard Business School. The offer letter states he may keep his Grab board seat.

When does Rogers start, and what does the visa condition mean?

The effective date in the 8-K is 1 October 2026, which the filing calls the Transition Date. The offer letter is more careful. It says his first day "is anticipated to be October 1, 2026, but is contingent upon you seeking the proper visa and/or work permits to enable you to legally work in the United States for Baxter."

CFO Dive reported the same condition on 20 August 2026. The job is based in Deerfield and is not remote. Under the letter, if Rogers has no US work authorization by his first day, he performs the CFO role from Baxter's offices in the United Kingdom until the visa is granted. After authorization, he relocates to Deerfield with relocation assistance.

This is a conditional start date, not a delay. Nothing in the filings says the visa has been refused or is at risk.

How much will Baxter pay John Rogers?

Baxter disclosed the full package in the 8-K and the offer letter. The figures below are Baxter's filed terms as of 19 August 2026.

The filing describes both off-cycle grants and the sign-on payment as replacing incentive pay he gives up at his prior employer. He must repay the sign-on payment in full if he leaves, or Baxter terminates him, within 12 months of his start date. Between 12 and 24 months, he repays 50%. Death, permanent disability and a qualifying severance-plan termination are excluded. Per the offer letter, the payment is made after 90 days of employment.

Smith+Nephew said that Rogers receives no severance from it and that his outstanding annual incentive, performance share and restricted share awards lapse on 30 September 2026 under ordinary leaver rules. The two companies' terms fit together: the lapsed awards are what the Baxter grants are meant to replace.

Why is Smith+Nephew losing its CFO?

Smith+Nephew said in a company announcement on 19 August 2026 that Rogers told the board, after the first half results, that he would leave on 30 September "to take up an external position in the US." He left the Smith+Nephew board with immediate effect, and a search for a successor has started.

The announcement does not name Baxter. The link comes from Baxter's own 8-K, which states that Rogers is "joining from Smith+Nephew," and from CFO Dive.

Pierre Palassian, Senior Vice President Finance and Group Controller, will serve as interim CFO until a successor is appointed. Smith+Nephew says he joined in June 2017 after senior roles at AbbVie and Abbott Laboratories. CEO Deepak Nath thanked Rogers for his work on the 12-Point Plan and the RISE strategy.

What happens to Baxter's finance leadership in the meantime?

Baxter's 8-K says Anita Zielinski, Interim CFO and Senior Vice President, Chief Accounting Officer and Controller, leaves on 15 September 2026. Hider then serves as interim CFO for an "anticipated two-week interim period" until 1 October. He keeps his CEO duties and receives no extra pay for the interim role.

Bernie Heine, the Assistant Controller, becomes interim Chief Accounting Officer and Controller from 15 September while a search for a permanent chief accounting officer runs. The 8-K says he receives $15,000 a month in that role and a one-time restricted stock unit award worth $250,000.

According to CFO Dive, Zielinski had been Baxter's temporary finance chief since CFO Joel Grade stepped down in March, and she joins Cardinal Health as chief accounting officer in November. Those two details come from that single outlet. Baxter's filing does not state them.

What did Baxter say about why it chose Rogers?

Baxter's press release quotes Hider directly. "John is a proven global finance executive with extensive operational expertise and a successful track record leading complex transformation initiatives," he said. He called Rogers "an ideal fit for Baxter as we continue to stabilize the business, strengthen our balance sheet."

These are the company's statements. The release adds that Rogers led WPP's global transformation program and a digital transformation of Argos' omnichannel business, also a company description. Baxter also reiterated its full-year 2026 outlook, which it had given with its earnings announcement on 30 July 2026. The release contains no figures.

What's still unclear?

Several points remain open as of 13 October 2026:

• Start date. Neither the filings nor the coverage cited here confirm that Rogers started on 1 October or that his US work authorization was granted. The 8-K reports the date as effective. The offer letter calls it anticipated.
• Smith+Nephew's successor. The company has not named a permanent CFO in the announcement. Palassian is interim.
• Naming the employer. Smith+Nephew's release does not name Baxter. The connection rests on Baxter's filing and press coverage.
• Signal for the turnaround. Hider's statement frames the hire around stabilizing the business and the balance sheet. The filings do not give a mandate, targets or a timeline for Rogers, so any reading of strategy is an inference, not a disclosed fact.
• Typo in the filing. The 8-K prints the performance period for one grant as "January 1, 2026 through December 21, 2028." The offer letter gives the same period as ending 31 December 2028, so the 8-K date looks like a typo.